模式识别受体的治疗向,以调节动脉样硬化中的炎症
Hongyan Su1, Xiancheng Wang1, Lu Wang1
1Cardiology Department, The Third Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, 130000, China.
Cell biochemistry and biophysics
|August 15, 2024
概括
动脉样硬化是一种心血管疾病,涉及由天生的免疫系统驱动的慢性炎症. 模式识别受体 (PRR) 是检测危险信号和促进这种炎症过程的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 心血管医学 心血管医学
- 炎症研究 炎症研究
背景情况:
- 动脉样硬化 (AS) 是一种慢性炎症心血管疾病 (CVD).
- 炎症和免疫机制显著影响AS发病和进展.
- 天生的免疫路径在AS进展中至关重要,检测危险信号和改变免疫细胞.
研究的目的:
- 审查先天免疫反应在动脉样硬化中的作用.
- 检查模式识别受体 (PRR) 在AS发展和进展中的贡献.
- 探索如何理解PRRs可以导致AS的新治疗策略.
主要方法:
- 文献综述侧重于先天免疫和动脉样硬化中的PRRs.
- 对心血管系统中PRR激活和炎症信号的当前研究进行分析.
- 综合关于PRRs对AS病变发生的影响的研究结果.
主要成果:
- 模式识别受体 (PRR) 识别了与病原体相关的分子模式和与危险相关的分子信号.
- 激活PRR会触发心血管系统内的炎症反应.
- 通过PRRs,先天免疫系统在AS形成和发展中发挥着根本性的作用.
结论:
- 天生的免疫反应,特别是通过PRRs,是动脉样硬化的主要原因.
- 准PRR为AS提供了新的治疗干预措施的潜力.
- 对PRR的进一步研究可以改善对AS相关炎症的理解和治疗.
相关概念视频
Inflammation
53.2K
Overview
53.2K
Inflammatory Response
1.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.9K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
120
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
120
T Cell Types and Functions
964
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
964
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K


